Akoya Biosciences, Inc. (AKYA) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Akoya Biosciences, Inc. (AKYA) Bundle
Evaluate Akoya Biosciences, Inc.'s (AKYA) financial outlook with expert precision! This (AKYA) DCF Calculator provides pre-filled financial data and allows you to easily modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.2 | 42.4 | 54.9 | 74.9 | 96.6 | 119.7 | 148.2 | 183.4 | 227.1 | 281.2 |
| Revenue Growth, % | 0 | 0.4901 | 29.39 | 36.31 | 29.09 | 23.82 | 23.82 | 23.82 | 23.82 | 23.82 |
| EBITDA | -9.6 | -10.1 | -35.2 | -58.8 | -45.6 | -56.6 | -70.1 | -86.8 | -107.4 | -133.0 |
| EBITDA, % | -22.78 | -23.86 | -64.04 | -78.57 | -47.22 | -47.29 | -47.29 | -47.29 | -47.29 | -47.29 |
| Depreciation | 3.1 | 3.8 | 4.8 | 7.1 | 8.9 | 10.5 | 12.9 | 16.0 | 19.9 | 24.6 |
| Depreciation, % | 7.23 | 8.99 | 8.73 | 9.55 | 9.2 | 8.74 | 8.74 | 8.74 | 8.74 | 8.74 |
| EBIT | -12.7 | -13.9 | -40.0 | -66.0 | -54.5 | -67.0 | -83.0 | -102.8 | -127.3 | -157.6 |
| EBIT, % | -30.01 | -32.85 | -72.76 | -88.12 | -56.42 | -56.03 | -56.03 | -56.03 | -56.03 | -56.03 |
| Total Cash | 21.7 | 17.0 | 113.1 | 81.2 | 83.1 | 90.3 | 111.8 | 138.5 | 171.4 | 212.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 13.2 | 6.5 | 9.4 | 9.7 | 17.0 | 22.5 | 27.9 | 34.6 | 42.8 | 53.0 |
| Account Receivables, % | 31.17 | 15.24 | 17.2 | 13 | 17.59 | 18.84 | 18.84 | 18.84 | 18.84 | 18.84 |
| Inventories | 4.1 | 4.3 | 9.0 | 14.5 | 17.9 | 17.7 | 21.9 | 27.1 | 33.6 | 41.6 |
| Inventories, % | 9.69 | 10.04 | 16.41 | 19.35 | 18.5 | 14.8 | 14.8 | 14.8 | 14.8 | 14.8 |
| Accounts Payable | 8.1 | 5.1 | 9.4 | 10.6 | 11.8 | 17.9 | 22.1 | 27.4 | 34.0 | 42.0 |
| Accounts Payable, % | 19.22 | 11.95 | 17.18 | 14.2 | 12.19 | 14.95 | 14.95 | 14.95 | 14.95 | 14.95 |
| Capital Expenditure | -2.9 | -3.3 | -5.1 | -7.4 | -3.7 | -9.0 | -11.1 | -13.7 | -17.0 | -21.1 |
| Capital Expenditure, % | -6.79 | -7.76 | -9.28 | -9.83 | -3.78 | -7.49 | -7.49 | -7.49 | -7.49 | -7.49 |
| Tax Rate, % | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 | -0.06320813 |
| EBITAT | -12.8 | -14.0 | -39.8 | -66.1 | -54.6 | -67.0 | -83.0 | -102.7 | -127.2 | -157.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.8 | -10.0 | -43.5 | -70.9 | -58.8 | -64.8 | -86.4 | -107.0 | -132.5 | -164.1 |
| WACC, % | 10.54 | 10.54 | 10.53 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -396.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -167 | |||||||||
| Terminal Value | -1,960 | |||||||||
| Present Terminal Value | -1,187 | |||||||||
| Enterprise Value | -1,584 | |||||||||
| Net Debt | 3 | |||||||||
| Equity Value | -1,587 | |||||||||
| Diluted Shares Outstanding, MM | 44 | |||||||||
| Equity Value Per Share | -35.71 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Akoya Biosciences, Inc.’s (AKYA) financial data pre-filled to accelerate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive Data Access: Obtain precise pre-loaded historical performance metrics and future growth forecasts for Akoya Biosciences, Inc. (AKYA).
- Adjustable Assumptions: Modify highlighted fields such as discount rates, growth projections, and profit margins to tailor your analysis.
- Real-Time Calculations: Automatic recalculations for Discounted Cash Flow (DCF), Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Intuitive charts and summaries that facilitate the visualization of your valuation insights.
- Designed for All Users: A user-friendly layout suitable for investors, financial officers, and consultants, regardless of experience level.
How It Works
- 1. Access the Template: Download and open the Excel file containing Akoya Biosciences, Inc.'s (AKYA) preloaded data.
- 2. Adjust Key Inputs: Modify essential parameters such as revenue growth, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various projections to understand a range of valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation findings to bolster your decision-making process.
Why Choose Akoya Biosciences (AKYA)?
- Precision: Leverages cutting-edge technology for accurate biological data analysis.
- Customization: Users can easily adapt and modify parameters to suit their research needs.
- Efficiency: Streamlines complex workflows, saving valuable research time.
- High-Quality Standards: Engineered with the expertise of industry leaders to ensure reliability.
- Intuitive Interface: Designed for ease of use, catering to both seasoned scientists and newcomers.
Who Should Use This Product?
- Investors: Evaluate Akoya Biosciences’ valuation prior to making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
- Biotech Entrepreneurs: Discover how leading biotech firms like Akoya are valued in the market.
- Consultants: Provide comprehensive valuation analyses and reports for clients in the biotech sector.
- Students and Educators: Utilize actual market data to learn and teach valuation strategies specific to biotechnology.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Akoya Biosciences, Inc. (AKYA).
- Real-World Data: Akoya's historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into the company's performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Akoya Biosciences, Inc. (AKYA).
- Dashboard with Visual Outputs: Engaging charts and tables providing clear, actionable results.